JPH10328269A - Medical container - Google Patents
Medical containerInfo
- Publication number
- JPH10328269A JPH10328269A JP9157568A JP15756897A JPH10328269A JP H10328269 A JPH10328269 A JP H10328269A JP 9157568 A JP9157568 A JP 9157568A JP 15756897 A JP15756897 A JP 15756897A JP H10328269 A JPH10328269 A JP H10328269A
- Authority
- JP
- Japan
- Prior art keywords
- container
- main body
- medical
- seal
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 claims abstract description 73
- 239000000463 material Substances 0.000 claims abstract description 18
- 230000001681 protective effect Effects 0.000 claims abstract description 14
- 230000001954 sterilising effect Effects 0.000 claims description 51
- 238000004659 sterilization and disinfection Methods 0.000 claims description 42
- 229920005989 resin Polymers 0.000 claims description 36
- 239000011347 resin Substances 0.000 claims description 36
- 239000000126 substance Substances 0.000 claims description 23
- 238000007789 sealing Methods 0.000 claims description 17
- 239000003566 sealing material Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 2
- 241000894006 Bacteria Species 0.000 abstract description 8
- 238000002156 mixing Methods 0.000 abstract description 7
- 230000006866 deterioration Effects 0.000 abstract description 4
- 239000007788 liquid Substances 0.000 abstract 5
- 238000004321 preservation Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 40
- 229940079593 drug Drugs 0.000 description 31
- 229920001971 elastomer Polymers 0.000 description 24
- 238000002955 isolation Methods 0.000 description 23
- 238000004891 communication Methods 0.000 description 19
- 239000005060 rubber Substances 0.000 description 17
- 239000010410 layer Substances 0.000 description 16
- 238000003860 storage Methods 0.000 description 14
- 238000001802 infusion Methods 0.000 description 13
- 239000007789 gas Substances 0.000 description 12
- 239000002775 capsule Substances 0.000 description 8
- 239000007924 injection Substances 0.000 description 8
- 239000000806 elastomer Substances 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 230000004888 barrier function Effects 0.000 description 5
- 230000002209 hydrophobic effect Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000002093 peripheral effect Effects 0.000 description 4
- -1 polyethylene Polymers 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000005062 Polybutadiene Substances 0.000 description 3
- 230000004308 accommodation Effects 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 229920002857 polybutadiene Polymers 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 229920005672 polyolefin resin Polymers 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 239000004945 silicone rubber Substances 0.000 description 3
- 229920002725 thermoplastic elastomer Polymers 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 2
- 229920000181 Ethylene propylene rubber Polymers 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229920005549 butyl rubber Polymers 0.000 description 2
- 229920003049 isoprene rubber Polymers 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008155 medical solution Substances 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- 239000000162 organ preservation solution Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- OEPOKWHJYJXUGD-UHFFFAOYSA-N 2-(3-phenylmethoxyphenyl)-1,3-thiazole-4-carbaldehyde Chemical compound O=CC1=CSC(C=2C=C(OCC=3C=CC=CC=3)C=CC=2)=N1 OEPOKWHJYJXUGD-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 244000043261 Hevea brasiliensis Species 0.000 description 1
- 229920000459 Nitrile rubber Polymers 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920006311 Urethane elastomer Polymers 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 239000004840 adhesive resin Substances 0.000 description 1
- 229920006223 adhesive resin Polymers 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 238000000071 blow moulding Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000008151 electrolyte solution Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 239000012943 hotmelt Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229920002681 hypalon Polymers 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 238000001746 injection moulding Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005022 packaging material Substances 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920006350 polyacrylonitrile resin Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920006124 polyolefin elastomer Polymers 0.000 description 1
- 239000005077 polysulfide Substances 0.000 description 1
- 229920001021 polysulfide Polymers 0.000 description 1
- 150000008117 polysulfides Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
- B65D81/3205—Separate rigid or semi-rigid containers joined to each other at their external surfaces
Landscapes
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Package Specialized In Special Use (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、医療用容器に関するも
のであり、より詳細には、他の薬剤、例えば、抗生物質
等の薬剤を無菌的に混注した後の薬液を投与する場合に
用いられる連結部付き医療用容器に関するものである。
特に、連結部の取付が簡単であること、連結部の無菌維
持及び安全性が高いこと、及び使用の際の混注、混合操
作が容易である医療用容器に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a medical container, and more particularly to a medical container used for administering a drug solution after aseptically co-injecting another drug such as an antibiotic. The present invention relates to a medical container with a connecting portion to be used.
In particular, the present invention relates to a medical container in which the attachment of the connecting portion is simple, the aseptic maintenance and safety of the connecting portion are high, and the co-injection and mixing operation at the time of use are easy.
【0002】[0002]
【従来の技術】点滴注射に用いられる輸液、透析液、臓
器保存液等のバック、コンテナ等の医療用容器は、一般
に樹脂容器である。また輸液にはその使用時に抗生物質
などが混注、混合された後に点滴注射されるものがあ
る。このような混注、或いは混合には注射器が使用され
る。例えば、抗生物質の入ったバイアルに溶解液が注射
器を介して入れられる。抗生物質と溶解液とが混合さ
れ、混合液は注射器でバイアル内から吸い戻される。そ
して、輸液容器の排出口に注射器が刺通され、その混合
液が輸液容器内に充填される。また、最近、かかる煩雑
操作を省略するため、医療用容器にバイアル等の連結部
を備えたものが種々提案されている。連結部を備えた医
療用容器には薬液或いは溶解液を収容した樹脂容器にバ
イアル等の連通手段のみを具備したものと、樹脂容器と
バイアル等の薬剤容器とを連結部で既に連結して、使用
時まで各容器内同士が連通されない状態におかれるもの
とがある。前者はいわゆるハーフキット医療用容器と一
般に称され、後者はフルキット医療用容器と称されてい
る。2. Description of the Related Art Medical containers such as bags and containers for infusions, dialysis solutions, organ preservation solutions and the like used for infusion are generally resin containers. In addition, some infusions are infused with antibiotics or the like at the time of use, and are then injected by infusion after mixing. A syringe is used for such co-injection or mixing. For example, a lysate is placed via a syringe into a vial containing the antibiotic. The antibiotic and the lysis solution are mixed, and the mixture is drawn back out of the vial with a syringe. Then, the syringe is pierced through the outlet of the infusion container, and the mixed solution is filled in the infusion container. Recently, various types of medical containers provided with a connecting portion such as a vial have been proposed in order to eliminate such complicated operations. The medical container provided with a connecting portion is provided with only a communicating means such as a vial to a resin container containing a drug solution or a solution, and the resin container and a drug container such as a vial are already connected at the connecting portion, Some containers remain in a state where they are not communicated with each other until use. The former is commonly referred to as a so-called half-kit medical container, and the latter is referred to as a full-kit medical container.
【0003】ハーフキット医療用容器としては、例え
ば、可撓性容器と、該容器の上端から上方に伸びる筒状
の収容カプセルとから構成され、カプセル内に連通手段
である両頭刺通型の連通針が収容され、使用時に連通針
の一端を薬剤容器の口部ゴム栓に刺通し、連通針の他端
を可撓性容器の上端に設けたゴム栓に刺通して薬剤容器
内と可撓性容器内とを連通させる薬剤容器の連通手段を
備えた溶解液容器が提案されている(特開平7−328
097号公報)。筒状カプセルの下部開口は可撓性容器
の上端に密封連結され、上部開口はシール部材によって
密封され、連通針はカプセル内に無菌的に収容されてい
る。フルキット医療用容器としては、例えば、溶解液容
器と、連結部として溶液容器の上端に設けた筒状のガイ
ドカプセルと、ガイドカプセル内を上下動可能に設けた
両頭刺通型の連通針と、バイアル等の薬剤容器と、内部
にその薬剤容器を保持するホルダーと、ホルダーを収容
しガイドカプセルの開口部を回動可能に密封するキャッ
プとからなる輸液用容器が提案されている(特開平7−
275324号公報)。かかる輸液用容器はキャップを
回転させることにより、ホルダーが回転することなく連
通針に向かって移動し、薬剤容器の口部ゴム栓は連通針
の一端に刺通され、また溶解液容器の連結部のゴム栓は
連通針の他端に刺通され、この結果薬剤容器内と溶解液
容器内とが連通されるものである。[0003] A half-kit medical container is composed of, for example, a flexible container and a cylindrical housing capsule extending upward from the upper end of the container. A needle is accommodated, and in use, one end of the communication needle is pierced into the rubber stopper at the mouth of the medicine container, and the other end of the communication needle is pierced through a rubber stopper provided at the upper end of the flexible container. A dissolving solution container provided with a communication means for a medicine container for communicating the inside with the inside has been proposed (JP-A-7-328).
No. 097). The lower opening of the cylindrical capsule is hermetically connected to the upper end of the flexible container, the upper opening is sealed by a sealing member, and the communication needle is aseptically accommodated in the capsule. As a full kit medical container, for example, a dissolving solution container, a cylindrical guide capsule provided at the upper end of the solution container as a connecting portion, and a double-head piercing type communication needle provided vertically movably in the guide capsule An infusion container has been proposed which comprises a medicine container such as a vial, a holder for holding the medicine container therein, and a cap for accommodating the holder and rotatably sealing the opening of the guide capsule (Japanese Patent Application Laid-Open No. HEI 9-208572). 7-
275324). By rotating the cap, the infusion container moves toward the communication needle without rotating the holder, the rubber stopper at the mouth of the medicine container is pierced into one end of the communication needle, and the connecting portion of the solution container is connected. The rubber stopper is pierced into the other end of the communication needle, and as a result, the inside of the medicine container and the inside of the solution container are connected.
【0004】[0004]
【発明が解決しようとする課題】しかしながら、従来の
連結部を具備した医療用容器には未だ以下の問題点があ
る。医療用容器に連結される薬剤容器内の薬剤はオート
クレーブ等の加熱滅菌ができないものが殆どである。こ
のため、薬剤は容器に無菌充填されてゴム栓で密封さ
れ、市場に提供される。無菌充填した薬剤は完全に無菌
状態に維持されているとは限らない。そこで、薬剤を薬
液に溶解する際に除菌フィルタを介して容器本体内に戻
すこと等が従来から考えられる。しかし、上記の各キッ
トでは除菌フィルタを樹脂容器内の薬液に晒した状態で
長期間の保存はできない。このため、薬液が薬剤容器に
流通するに際しての除菌フィルタの上流側及び下流側に
それぞれ本体内及び薬剤容器の口部に連通するための連
通針を設けて除菌フィルタを使用まで乾燥状態に置く必
要がある。また上流側に設けられる連通針に無菌状態が
十分に確保されていなければ、混合液の無菌維持が損な
われる。従って、除菌フィルタの両側に連通手段を連結
部に無菌的に設ける必要がある。更に、連通手段はカプ
セル内で移動可能に無菌状態に維持して設ける必要があ
る。特に、その移動に際しては薬剤容器の口部が可撓性
容器のゴム栓より先に連通針で刺通されなければならな
いという構成要件が課せられるため、カプセル内の収容
構造が更に複雑となるおそれがある。また可撓性容器の
連結部或いは連結口にゴム栓を設ける必要があり、また
使用に際して可撓性容器のゴム栓にも連通針を刺通する
等の操作が必要であるため、その連通操作が必ずしもス
ムーズに行えるとは限らない。従って、本発明は、連結
部の取付が簡単で、連結部の無菌維持及び安全性が高
く、更には使用の際の混注、混合操作が容易にできる医
療用容器を提供することを目的としている。However, the medical container provided with the conventional connecting portion still has the following problems. Most of the medicine in the medicine container connected to the medical container cannot be sterilized by heating such as an autoclave. For this purpose, the drug is aseptically filled in a container, sealed with a rubber stopper and provided to the market. Aseptically filled drugs are not always maintained completely sterile. Therefore, it is conventionally considered to return the drug to the inside of the container via a sterilization filter when dissolving the drug in the drug solution. However, in each of the above-mentioned kits, long-term storage cannot be performed in a state where the sterilization filter is exposed to the chemical solution in the resin container. For this reason, communication needles for communicating with the inside of the main body and the mouth of the medicine container are provided on the upstream side and the downstream side of the sterilization filter when the medical solution flows through the medicine container, and the sterilization filter is kept in a dry state until use. Need to put. If the communication needle provided on the upstream side is not sufficiently aseptic, the aseptic maintenance of the mixture is impaired. Therefore, it is necessary to aseptically provide communication means on both sides of the sterilization filter at the connection portion. Further, it is necessary to provide the communicating means so as to be movable within the capsule and to be kept in a sterile state. In particular, when moving the medicine container, a constituent requirement that the mouth portion of the medicine container must be pierced with a communication needle before the rubber stopper of the flexible container is imposed, so that the accommodation structure in the capsule may be further complicated. There is. Further, it is necessary to provide a rubber stopper at the connection part or the connection port of the flexible container, and it is necessary to pierce the rubber stopper of the flexible container with a communication needle at the time of use. Is not always smooth. Accordingly, an object of the present invention is to provide a medical container in which the connecting portion can be easily attached, aseptic maintenance and safety of the connecting portion are high, and co-injection and mixing operation at the time of use can be easily performed. .
【0005】[0005]
【課題を解決するための手段】本発明は、薬液が収容さ
れた樹脂製の本体であって、上記薬液に混注される薬剤
を収容した薬剤容器を連結するための連結部を有する本
体からなる医療用容器において、上記本体に隔離シール
部を形成し、該隔離シール部で上記薬液の収容部と上記
連結部とを隔離し、上記隔離シール部を剥離可能なシー
ル部とすると共に、上記連結部の連結口に弾性リング材
及び除菌フィルタを設け、上記連結口と薬剤容器の口部
とは弾性リング材及び除菌フィルタを介して液密に連結
しうることを特徴とする医療用容器を提供することによ
り、上記目的を達成したものである。According to the present invention, there is provided a resin-made main body containing a chemical solution, the main body having a connecting portion for connecting a medicine container containing a medicine mixed with the chemical solution. In the medical container, an isolation seal portion is formed on the main body, the isolation seal portion isolates the storage section for the chemical solution from the connection portion, and the isolation seal portion is a peelable seal portion, and the connection portion is separated. A medical container characterized in that an elastic ring material and a sterilization filter are provided at a connection port of the portion, and the connection port and the mouth of the medicine container can be liquid-tightly connected via the elastic ring material and the sterilization filter. The above object has been achieved by providing the above.
【0006】上記樹脂容器の本体に収容される薬液は一
般に電解質液である。例えば、乳酸、酢酸、重炭酸等を
含むリンゲル液、糖、アミノ酸、ペプチド、脂肪等を含
む高カロリー輸液、透析液、臓器保存液等の溶液であ
る。尚、薬液は凍結乾燥薬剤の単なる溶解液、希釈液で
も良く、かかる薬液は単純な無菌水であっても良い。薬
液は、樹脂容器内に液密に収容された後に蒸気滅菌処理
されるものである。蒸気滅菌処理は温度100℃〜14
0℃、特に温度105℃〜115℃の範囲で滅菌処理す
ることが望ましい。上記範囲を下回る滅菌温度では、時
間がかかり、また滅菌が不十分となるおそれがある。一
方、上記範囲を上回る滅菌温度ではプラスチック容器や
包装材が熱変形、熱変質等を起こして好ましくない。The chemical solution contained in the main body of the resin container is generally an electrolyte solution. Examples thereof include Ringer's solution containing lactic acid, acetic acid, bicarbonate and the like, high calorie infusion containing sugar, amino acid, peptide, fat, etc., dialysate, organ preservation solution and the like. The chemical may be a simple solution or dilution of the lyophilized drug, and the chemical may be simple sterile water. The chemical is steam sterilized after being housed in a resin container in a liquid-tight manner. Steam sterilization temperature is 100 ℃ ~ 14
It is desirable to sterilize at 0 ° C., particularly at a temperature of 105 ° C. to 115 ° C. At a sterilization temperature below the above range, it takes time and sterilization may be insufficient. On the other hand, if the sterilization temperature exceeds the above range, the plastic container and the packaging material are undesirably subjected to thermal deformation, thermal deterioration and the like.
【0007】上記樹脂容器は可撓性壁を有する。可撓性
壁は撓むことにより容器内の容積が容易に変化するもの
であれば良い。また、樹脂容器壁は内容物の確認できる
程度に透明性を有することが望ましい。容器内での薬液
の状態を確認する上で必要となるからである。上記樹脂
容器はインフレーションフィルム、チューブ、シート及
びフィルムから成形したもの、押出成形、射出成形、又
はブロー成形したものである。医療用容器の樹脂素材と
してはポリオレフィン系樹脂、塩化ビニル、塩化ビニリ
デン系樹脂、ポリエステル系樹脂、ポリビニルアルコー
ル系樹脂、ポリアクリルニトリル系樹脂、ポリアクリル
酸系樹脂、ポリアミド系樹脂等の汎用樹脂である。また
樹脂容器は単層又は多層で形成されていても良い。樹脂
容器内の薬剤と接触する最内層は、薬剤に影響を与えな
い、また溶出物が生じない樹脂層であることが望まし
い。このような樹脂としては、ポリオレフィン系樹脂が
望ましく、例えば、低、中、高−密度ポリエチレン、ポ
リプロピレン等の低級オレフィン樹脂等が挙げられる。
また、樹脂容器壁にはガスバリアー性層が形成されてい
ることが望ましい。特に、酸素等を容易に透過しない層
であることが望ましい。このようなガスバリアー性層と
しては、殆ど、又は全くガスを透過させないアルミニウ
ム等の金属層や酸化珪素、酸化マグネシウム、酸化チタ
ン等の無機蒸着層であり、またポリ塩化ビニリデン、ポ
リエステル、ナイロン、エチレン−ビニルアルコール共
重合体、フッ素系樹脂等のようにガスバリアー性の高い
樹脂層である。樹脂容器におけるガスバリアー性層の酸
素透過量は40cc・20μ/m2・day・atm
(温度:20℃)以下、特に、30cc・20μ/m2
・day・atm以下、また好ましくは5cc・20μ
/m2・day・atm以下、更には1cc・20μ/
m2・day・atm以下であることが望ましい。また
樹脂容器の壁は上述のように内部の薬剤が確認できる程
度に透明性を有することが望まれる。このため、ガスを
全く透過させない優れた機能を有する上記アルミニウム
層等の金属層から成る壁は少なくとも一部においてその
金属層が剥離可能に形成されていることが望ましい。か
かる層を有した樹脂容器においては高圧蒸気滅菌の加熱
時に薬剤の変質を十分に防止することができる。[0007] The resin container has a flexible wall. The flexible wall may be any as long as the volume in the container is easily changed by bending. Further, it is desirable that the resin container wall has transparency to the extent that the contents can be confirmed. This is necessary for confirming the state of the chemical solution in the container. The resin container is formed from an inflation film, a tube, a sheet, and a film, or is formed by extrusion, injection, or blow molding. The resin material of the medical container is a general-purpose resin such as polyolefin resin, vinyl chloride, vinylidene chloride resin, polyester resin, polyvinyl alcohol resin, polyacrylonitrile resin, polyacrylic acid resin, polyamide resin, and the like. . Further, the resin container may be formed in a single layer or a multilayer. The innermost layer in contact with the drug in the resin container is desirably a resin layer that does not affect the drug and does not generate elutes. As such a resin, a polyolefin-based resin is desirable, and examples thereof include low-, middle-, and high-density lower-grade olefin resins such as polyethylene and polypropylene.
It is desirable that a gas barrier layer is formed on the resin container wall. In particular, a layer that does not easily transmit oxygen or the like is desirable. Examples of such a gas barrier layer include a metal layer made of aluminum or the like which hardly transmits gas at all or an inorganic vapor-deposited layer made of silicon oxide, magnesium oxide, titanium oxide, etc., and polyvinylidene chloride, polyester, nylon, ethylene, and the like. -A resin layer having a high gas barrier property, such as a vinyl alcohol copolymer and a fluororesin. The oxygen permeation amount of the gas barrier layer in the resin container is 40 cc · 20 μ / m 2 · day · atm
(Temperature: 20 ° C.) or less, especially 30 cc · 20 μ / m 2
・ Day ・ atm or less, preferably 5cc ・ 20μ
/ M 2 · day · atm or less, and 1 cc · 20μ /
Desirably, it is equal to or less than m 2 · day · atm. Further, it is desired that the wall of the resin container has such transparency that the medicine inside can be confirmed as described above. For this reason, it is desirable that at least a part of the wall made of a metal layer such as the aluminum layer having an excellent function of not allowing gas to permeate at all be formed so that the metal layer can be peeled off. In the resin container having such a layer, deterioration of the medicine can be sufficiently prevented at the time of heating in high-pressure steam sterilization.
【0008】樹脂容器の本体は薬剤容器内と連通するた
めの連結部を有している。連結部は本体内と本体外とを
連通する通路からなり、連結部は本体に取付け或いは一
体成形される筒部材であっても良い。上記本体には隔離
シール部が形成され、上記薬液の収容部と上記連結部の
取付部分とは隔離シール部により隔離される。かかる隔
離により容器の保存中に薬液が連結部まで浸透し、後述
の除菌フィルタ等を濡らすおそれがない。上記隔離シー
ル部は本体の胴部内壁同士を液密シールした密着シール
であり、上記隔離シール部は接着剤を介した液密なシー
ル或いは樹脂同士の熱溶着シール等を挙げることができ
る。接着剤としては、ケトン系溶媒、エステル系溶媒、
エーテル系溶媒、炭化水素系溶媒、ハロゲン化炭化水素
系溶媒などの溶媒接着剤、或いは変性オレフィン類、ホ
ットメルト類等の樹脂接着剤を介した密封シール等があ
る。また熱溶着シールとしては、ヒートシール、インパ
ルスシール等の外部加熱による接着、又は超音波接合、
高周波接合等の内部加熱による接着等を挙げることがで
きる。特に、隔離シール部は熱溶着シールが好ましい。
熱溶着シールであれば、本体の外壁側からのシールが可
能となり、シールの際に本体内を汚染するおそれがな
い。[0008] The main body of the resin container has a connecting portion for communicating with the inside of the medicine container. The connecting portion includes a passage communicating the inside of the main body with the outside of the main body, and the connecting portion may be a cylindrical member attached to or integrally formed with the main body. An isolation seal portion is formed on the main body, and the accommodation portion for the chemical solution and the attachment portion of the connection portion are isolated by the isolation seal portion. Due to such isolation, there is no danger that the chemical solution permeates to the connecting portion during storage of the container and wets a sterilizing filter or the like described later. The isolation seal portion is a close-contact seal in which the body inner walls of the main body are liquid-tightly sealed, and the isolation seal portion may be a liquid-tight seal via an adhesive or a heat-sealing seal between resins. As an adhesive, a ketone solvent, an ester solvent,
There is a hermetic seal via a solvent adhesive such as an ether solvent, a hydrocarbon solvent, or a halogenated hydrocarbon solvent, or a resin adhesive such as a modified olefin or a hot melt. In addition, as the heat welding seal, heat sealing, adhesion by external heating such as impulse seal, or ultrasonic bonding,
Adhesion by internal heating such as high-frequency bonding can be given. In particular, a heat sealing seal is preferable for the isolation seal portion.
With a heat-sealed seal, sealing can be performed from the outer wall side of the main body, and there is no risk of contaminating the inside of the main body during sealing.
【0009】上記隔離シール部は剥離可能なシールであ
る。剥離可能なシールは、通常ピールシール或いは弱シ
ールとも称され、外部から容器の室或いは容器を圧迫
し、内部が一定の昇圧状態にさせたときに剥離すること
ができるようなシール、或いは容器外壁のそれぞれを把
持して引っ張ったときに剥離することのできるシール等
である。このような密着シールの剥離強度は、容器等の
室内の圧が0.01〜1.0Kgf/cm2、特に、
0.05〜0.5Kgf/cm2の昇圧で剥離する強度
が望ましい。上記範囲を下回る強度であれば、製造、運
搬、保存時等の隔離状態を保つための安全性に欠ける。
上記範囲を上回る強度であれば、用時に室と室同士の連
通操作を容易にすることができなくなるおそれがある。
上記ピールシールを形成する場合に、両者の接着樹脂層
が異なる樹脂のブレンド物であることが望ましい。特
に、異なる樹脂は、熱溶融開始温度、或いはピカッド軟
化点が異なり、相溶性のあまりない樹脂ブレンド物から
なることが望ましい。かかるブレンド物層を有すること
より、ピールシール接着のシール温度条件設定が簡単に
できる。また、ピールシール接着に求められるシール強
度、即ち、使用時の外力による易剥離性と、保存時に剥
離が生じないシール強度との関係を厳密に設定すること
ができる。即ち、内層に相溶性の異なる樹脂を溶融混合
し、これをシート状に成形することによって、ミクロ的
に熱接着性の異なる部分に分離した表面としたものであ
る。そして、任意の温度におけるその接着表面相互のミ
クロ的な部分の熱溶融性を決めることにより、シール強
度の強弱を正確に付け、上記効果を容易に達成するもの
である。[0009] The isolation seal is a peelable seal. The peelable seal is usually called a peel seal or a weak seal, and is a seal that can be peeled off when the inside of the container or the container is squeezed from the outside and a constant pressure is raised, or the outer wall of the container. Is a seal or the like that can be peeled off when each of them is gripped and pulled. The peel strength of such a close-contact seal is such that the pressure inside a chamber such as a container is 0.01 to 1.0 kgf / cm 2 ,
It is desirable to have a peeling strength at a pressure of 0.05 to 0.5 kgf / cm 2 . If the strength is lower than the above range, the safety for maintaining an isolated state at the time of production, transportation, storage and the like is lacking.
If the strength exceeds the above range, there is a possibility that the communication operation between the rooms cannot be easily performed at the time of use.
When the peel seal is formed, it is desirable that both adhesive resin layers are blends of different resins. In particular, it is desirable that the different resins be made of resin blends having different hot-melting onset temperatures or Picad softening points and little compatibility. By having such a blended material layer, it is possible to easily set the sealing temperature conditions for peel seal bonding. Further, the relationship between the seal strength required for peel seal adhesion, that is, the easy peelability due to external force during use, and the seal strength that does not cause peeling during storage can be strictly set. That is, a resin having different compatibility is melt-mixed in the inner layer, and this is formed into a sheet to form a surface which is microscopically separated into portions having different thermal adhesiveness. Then, by determining the thermal fusibility of the microscopic portion between the bonding surfaces at an arbitrary temperature, the strength of the sealing strength is accurately provided, and the above-described effect is easily achieved.
【0010】上記連結部の連結口に弾性リング材及び除
菌フィルタが設けられている。弾性リング材は薬剤容器
の口部が当接したとき、連結口と口部とを液密に密封し
うるシーリング材である。弾性リング材はゴム、熱可塑
性エラストマー等の弾性材からなる。ゴムとしては天然
ゴム、イソプレンゴム、スチレンゴム、ブタジェンゴ
ム、ニトリルゴム、エチレンプロピレンゴム、ブチルゴ
ム、シリコーンゴム、クロロプレンゴム、アクリルゴ
ム、クロロスルホン化ポリエチレンゴム、ヒドリンゴ
ム、ウレタンゴム、多硫化ゴム、フッ素ゴム、1−2ブ
タジェンゴム等を挙げることができる。熱可塑性エラス
トマとしては、スチレン系エラストマー、塩化ビニル系
エラストマー、オレフィン系エラストマー、ポリエステ
ル系エラストマー、ポリアミド系エラストマー、ウレタ
ン系エラストマー等を挙げることができる。医療用ゴム
として、イソプレンゴム、ブタジェンゴム、エチレンプ
ロピレンゴム、ブチルゴム、シリコンゴム等が望まし
く、熱可塑性エラストマーとして、オレフィン系エラス
トマー、ポリエステル系エラストマー等が望ましい。除
菌フィルタは、その孔径が0.8μm以下、好ましくは
0.45μm以下、特に0.22μm以下であることが
望ましい。上記範囲を上回る孔径のフィルタでは十分に
除菌できないおそれがあり、上記範囲内であれば除菌効
果が期待できる。特に、孔径が0.45μm以下では殆
どの細菌の除去が可能であり、孔径が0.22μm以下
では細菌破壊による除粒子効果も期待できる。除菌フィ
ルタはエチレンオキサイドガス滅菌処理或いは高圧蒸気
滅菌処理可能な素材であることが望ましく、このような
素材としてはセルロース混合エステル、ポリビニリデン
フロライド等を挙げることができる。本発明に係る除菌
フィルタは大部分が水溶液を透過させる親水性フィルタ
であるが、一部においてエア抜けの疎水性部を有するフ
ィルタであることが望ましい。例えば、全体が親水性フ
ィルタで周縁が疎水性機能を有する周縁疎水性フィルタ
等である。[0010] An elastic ring material and a sterilization filter are provided at a connection port of the connection portion. The elastic ring material is a sealing material capable of sealing the connection port and the mouth in a liquid-tight manner when the mouth of the medicine container abuts. The elastic ring member is made of an elastic material such as rubber or thermoplastic elastomer. Rubbers include natural rubber, isoprene rubber, styrene rubber, butadiene rubber, nitrile rubber, ethylene propylene rubber, butyl rubber, silicone rubber, chloroprene rubber, acrylic rubber, chlorosulfonated polyethylene rubber, hydrin rubber, urethane rubber, polysulfide rubber, fluorine rubber, 1-2 butadiene rubber and the like can be mentioned. Examples of the thermoplastic elastomer include a styrene-based elastomer, a vinyl chloride-based elastomer, an olefin-based elastomer, a polyester-based elastomer, a polyamide-based elastomer, and a urethane-based elastomer. As the medical rubber, isoprene rubber, butadiene rubber, ethylene propylene rubber, butyl rubber, silicone rubber, and the like are desirable, and as the thermoplastic elastomer, an olefin elastomer, a polyester elastomer, and the like are desirable. It is desirable that the sterilizing filter has a pore diameter of 0.8 μm or less, preferably 0.45 μm or less, and particularly preferably 0.22 μm or less. A filter having a pore size exceeding the above range may not be able to sufficiently remove bacteria, and within the above range, a bacteria removing effect can be expected. In particular, when the pore size is 0.45 μm or less, most bacteria can be removed, and when the pore size is 0.22 μm or less, an effect of removing particles by destruction of bacteria can be expected. The sterilizing filter is preferably made of a material that can be subjected to ethylene oxide gas sterilization or high-pressure steam sterilization, and examples of such a material include cellulose mixed esters and polyvinylidene fluoride. Most of the sterilization filter according to the present invention is a hydrophilic filter that allows an aqueous solution to pass therethrough, but it is desirable that a filter having a hydrophobic portion from which air is partially leaked is used. For example, a peripheral hydrophobic filter or the like having an entirely hydrophilic filter and a peripheral edge having a hydrophobic function.
【0011】このように構成される医療用容器にあって
は、連結部には弾性リング材及び除菌フィルタの取付で
十分であり、連通手段としての連通針等を移動可能に設
ける必要がない。保存時にあっては除菌フィルタを薬液
等に濡らした状態にしないため保存中にフィルタ機能を
低下させるおそれがない。医療用容器を使用する場合は
薬剤容器の口部を連結口に液密に連結し、その後、容器
本体を圧迫するのみで隔離シール材を剥離し、薬液を除
菌フィルタを介して薬剤容器内に一部注入する。薬剤を
薬液に溶解した後、その溶解液を再び容器本体内に戻
し、混注操作を完了させる。この場合、薬剤容器は連結
口に気密に連結でき、また予め連結口に無菌的に連結し
ておくこともできる。従って、医療用容器は連結部の組
立取付が簡単にでき、その連結部の無菌維持及び安全性
が十分になされ、使用の際の混注、混合操作が容易にで
きる。In the medical container constructed as described above, it is sufficient to attach an elastic ring material and a sterilizing filter to the connecting portion, and it is not necessary to movably provide a communication needle or the like as communication means. . At the time of storage, the sterilizing filter is not wetted with a chemical solution or the like, so that there is no possibility that the filter function is deteriorated during storage. When a medical container is used, the mouth of the medicine container is connected to the connection port in a liquid-tight manner, and thereafter, the isolation sealing material is peeled off only by pressing the container body, and the medicine is passed through the sterilization filter into the medicine container. Partly. After dissolving the drug in the drug solution, the solution is returned into the container body again to complete the co-injection operation. In this case, the medicine container can be airtightly connected to the connection port, or can be aseptically connected to the connection port in advance. Therefore, in the medical container, the connecting portion can be easily assembled and attached, the sterility of the connecting portion can be sufficiently maintained and the safety can be sufficiently achieved, and the co-injection and mixing operation at the time of use can be easily performed.
【0012】本発明に係る請求項2記載の医療用容器
は、請求項1記載の医療用容器において、上記連結口に
保護シール材を気密に貼着し、上記保護シール材は通気
性シートからなり、上記連結部内を上記容器本体内と共
に蒸気滅菌処理していることを特徴とする。保護シール
材は高圧蒸気滅菌時やエチレンオキサイドガス滅菌時に
水蒸気及びガスを容易に通気させるシートである。尚、
シートはフィルムも含むものである。このような通気性
を有するシートであれば、高圧蒸気滅菌処理或いはガス
滅菌処理時に連結部内に水蒸気或いはガスが浸透し、連
結部内及び除菌フィルタが確実に滅菌処理される。ま
た、高圧蒸気滅菌処理であれば、その滅菌後に連結部内
に生じた水分も保護シール材を介して容易に出すことが
できる。シール材の通気度は100秒/100ml以
下、好ましくは42秒/100ml以下、特に18秒/
100ml以下であることが望ましい。このようなシー
ル材により、保存中から使用時までの間、連結口を清潔
に維持させておくことができ、除菌フィルタを痛めるこ
ともない。According to a second aspect of the present invention, there is provided the medical container according to the first aspect, wherein a protective sealing material is hermetically adhered to the connection port, and the protective sealing material is formed of a breathable sheet. Wherein the inside of the connecting portion is steam-sterilized together with the inside of the container body. The protective sealing material is a sheet that easily allows water vapor and gas to pass during high-pressure steam sterilization and ethylene oxide gas sterilization. still,
Sheets also include films. With such a breathable sheet, steam or gas permeates into the connecting portion during high-pressure steam sterilization or gas sterilization, and the inside of the connecting portion and the sterilization filter are reliably sterilized. In addition, in the case of high-pressure steam sterilization, moisture generated in the connecting portion after the sterilization can be easily discharged through the protective seal material. The air permeability of the sealing material is 100 seconds / 100 ml or less, preferably 42 seconds / 100 ml or less, particularly 18 seconds / 100 ml.
It is desirable that the volume be 100 ml or less. With such a sealing material, the connection port can be kept clean from storage to use, and the sterilizing filter is not damaged.
【0013】本発明に係る請求項3記載の医療用容器は
請求項1記載の医療用容器において、上記連結口には上
記他の薬剤容器が既に設けられ、上記薬剤容器内は上記
本体内と通じていることを特徴とする。本発明に係る医
療用容器において、連結口に他の薬剤容器を予め取り付
けたフルキット医療用容器とすることができる。このよ
うな医療用容器にあっては、その保存時において連結口
が無菌に維持されるだけでなく、その使用時に隔離シー
ル部を剥離するのみで樹脂容器の本体内と薬剤容器内と
を簡単に連通させることができる。また、除菌フィルタ
を介して連通されるため、一旦薬剤容器に流通した薬液
が再び本体内に戻る際に除菌フィルタにより確実な除菌
処理が成される。このため、医療用容器の使用の際に汚
染を起こすおそれがない。また、このような医療用容器
にあってはその連結部が筒状連結部材、シール部材及び
除菌フィルタのみで構成され、極めて部品点数が少なく
なる。The medical container according to a third aspect of the present invention is the medical container according to the first aspect, wherein the other drug container is already provided at the connection port, and the inside of the drug container is connected to the inside of the main body. It is characterized by communication. In the medical container according to the present invention, a full kit medical container in which another drug container is previously attached to the connection port can be provided. In such medical containers, not only the connection port is kept sterile during storage, but also the resin seal body and drug container can be easily separated by simply peeling off the isolation seal during use. Can be communicated with. In addition, since the communication is performed via the sterilization filter, when the medical solution once circulated in the medicine container returns to the inside of the main body, the sterilization filter surely performs the sterilization process. Therefore, there is no possibility of causing contamination when the medical container is used. Further, in such a medical container, the connecting portion is constituted only by the cylindrical connecting member, the sealing member and the sterilization filter, and the number of parts is extremely reduced.
【0014】[0014]
【実施例】以下、本発明に係る医療用容器の好ましい実
施例を添付図面を参照しながら詳述する。図1は本発明
に係る医療用容器の第一実施例の正面図である。図2は
第一実施例の医療用容器の使用時の正面図である。図3
は第一実施例の医療用容器に用いる除菌フィルタの正面
図である。DESCRIPTION OF THE PREFERRED EMBODIMENTS Preferred embodiments of the medical container according to the present invention will be described below in detail with reference to the accompanying drawings. FIG. 1 is a front view of a first embodiment of the medical container according to the present invention. FIG. 2 is a front view when the medical container of the first embodiment is used. FIG.
FIG. 2 is a front view of a sterilization filter used for the medical container of the first embodiment.
【0015】図1に示す如く第一実施例の医療用容器1
は、薬液3が収容された樹脂製の本体2であって、薬液
3に混注される薬剤5を収容した薬剤容器4を連結する
ための連結筒部材11を有する本体からなる。医療用容
器1は、上記本体2に隔離シール部12を形成し、隔離
シール部12で薬液3の収容部2Aと連結筒部材11と
を隔離し、隔離シール部12を剥離可能なシール部とす
ると共に、連結筒部材11の連結口13に弾性リング材
14及び除菌フィルタを15設け、連結口13と薬剤容
器4の口部4Aとは弾性リング材14及び除菌フィルタ
15を介して液密に連結しうるものである。上記連結口
13に保護シール材16を気密に貼着し、保護シール材
16は通気性シートからなり、上記連結筒部材11内が
蒸気滅菌処理されている。As shown in FIG. 1, a medical container 1 according to the first embodiment is shown.
Is a resin main body 2 in which the chemical solution 3 is housed, and is composed of a main body having a connecting cylinder member 11 for connecting the medicine container 4 in which the medicine 5 mixed with the medicine solution 3 is housed. The medical container 1 has an isolation seal portion 12 formed on the main body 2, the isolation seal portion 12 isolates the accommodating portion 2 </ b> A of the drug solution 3 from the connecting cylinder member 11, and a seal portion capable of peeling the isolation seal portion 12. At the same time, an elastic ring material 14 and a sterilization filter 15 are provided in the connection port 13 of the connection cylinder member 11. It can be closely connected. A protective seal member 16 is hermetically adhered to the connection port 13, and the protective seal member 16 is formed of a breathable sheet. The inside of the connection tube member 11 is subjected to steam sterilization.
【0016】第一実施例の医療用容器1を更に説明する
と、容器本体2は厚み250μmのインフレーションフ
ィルムを所定の長さに裁断し、裁断端部を熱溶着シール
して成形されている。本体2の端部シール7には連結筒
部材11が熱溶着の際に取り付けられ、端部シール8に
は排出用口部材9が取り付けられている。連結筒部材1
1及び排出用口部材9はポリエチレン製の射出成形物か
らなる。連結筒部材11の一の開放端17は本体2内に
配され、他の開放端である連結口13は本体2外に配さ
れ、連結口13にはフック顎18が形成されている。フ
ック顎18内には弾性リング材14及び除菌フィルタ1
5が配されている。図2に示す如く薬剤容器4の口部4
Aがフック顎18内に挿入されたとき、口部4Aは弾性
リング材14に当接され、薬剤容器4内と連結部材11
内とが液密に連結される。保存時、図1に示す如く薬剤
容器4の口部4Aが連結口13に連結されていない時に
は連結口13に保護シール材16が気密に貼着されてい
る。本体2内には一条の隔離シール部12が形成され、
隔離シール部12は容器本体2を二室に区分している。
収容室2Aには薬液3が収容され、薬液3は隔離シール
部12により連結筒部材11と接触しないようになって
いる。排出用口部材9内には閉止用のゴム栓が設けられ
ており、薬液3は収容室2Aに液密に収容されている。
薬液3及び除菌フィルタ15は本体2と共に高圧蒸気滅
菌処理されている。To further explain the medical container 1 of the first embodiment, the container main body 2 is formed by cutting a blown film having a thickness of 250 μm into a predetermined length and sealing the cut end by heat sealing. A connecting tubular member 11 is attached to the end seal 7 of the main body 2 at the time of heat welding, and a discharge port member 9 is attached to the end seal 8. Connecting cylinder member 1
1 and the outlet member 9 are made of an injection molded product made of polyethylene. One open end 17 of the connecting cylinder member 11 is disposed inside the main body 2, and a connecting port 13, which is another open end, is disposed outside the main body 2, and a hook jaw 18 is formed on the connecting port 13. The elastic ring material 14 and the sterilizing filter 1 are provided in the hook jaw 18.
5 are arranged. The mouth 4 of the medicine container 4 as shown in FIG.
When A is inserted into the hook jaw 18, the mouth 4 </ b> A comes into contact with the elastic ring member 14, and the inside of the medicine container 4 and the connecting member 11 are connected.
The inside is connected in a liquid-tight manner. At the time of storage, as shown in FIG. 1, when the mouth 4A of the medicine container 4 is not connected to the connection port 13, the protective sealing material 16 is hermetically attached to the connection port 13. A single isolation seal portion 12 is formed in the main body 2,
The isolation seal portion 12 divides the container body 2 into two chambers.
The chemical solution 3 is accommodated in the accommodation chamber 2 </ b> A, and the chemical solution 3 is prevented from contacting the connecting cylinder member 11 by the isolation seal portion 12. A rubber stopper for closing is provided in the discharge port member 9, and the chemical solution 3 is stored in the storage chamber 2 </ b> A in a liquid-tight manner.
The chemical solution 3 and the sterilization filter 15 are subjected to high-pressure steam sterilization together with the main body 2.
【0017】上記薬液3は連結口13に連結される容器
4内の薬剤5の溶解液であり、上述のように滅菌処理が
なされている。上記隔離シール部12は熱溶着シール部
である。隔離シール部12のヒートシール温度は140
℃以下で行われ、上述の本体の端部シール7、8のヒー
トシール温度は160℃以上で行われている。このた
め、隔離シール部12は剥離可能なピールシール形成さ
れ、端部シール7、8は無理に剥離しようとすると容器
壁が破壊される固着シール形成されている。上記弾性リ
ング材14はシリコーンゴムからり、いわゆるオーリン
グと称されている。上記除菌フィルタ15は孔径が0.
22μmの親水性フィルタからなる。図3に示す如く除
菌フィルタ15はその周縁15Aが疎水処理され、周縁
15Aにエア抜けの疎水フィルタ部分が形成されてい
る。保護シール材16はポリプロピレン繊維を含む混合
紙からなり、20秒/100mlの通気度を有してい
る。このため、本体2の高圧蒸気滅菌後、連通筒部材1
1内の水分を容易に除去することができるようになって
いる。The drug solution 3 is a solution of the drug 5 in the container 4 connected to the connection port 13, and has been sterilized as described above. The isolation seal portion 12 is a heat-sealing seal portion. The heat sealing temperature of the isolation seal portion 12 is 140
C. or lower, and the heat sealing temperature of the end seals 7 and 8 of the main body is 160 C. or higher. For this reason, the separating seal portion 12 is formed as a peelable peel seal, and the end seals 7 and 8 are formed as a fixed seal that breaks the container wall when the forcible peeling is attempted. The elastic ring member 14 is made of silicone rubber and is called an O-ring. The sterilizing filter 15 has a pore size of 0.
It consists of a 22 μm hydrophilic filter. As shown in FIG. 3, the sterilizing filter 15 has a peripheral edge 15A subjected to a hydrophobic treatment, and a hydrophobic filter portion from which air is removed is formed on the peripheral edge 15A. The protective sealing material 16 is made of a mixed paper containing polypropylene fibers, and has an air permeability of 20 seconds / 100 ml. For this reason, after the high-pressure steam sterilization of the main body 2,
1 can be easily removed.
【0018】このように構成される医療用容器1にあっ
ては、樹脂製の容器本体2、連結筒部材11、弾性リン
グ、及び除菌フィルタとからなり、極めて少ない部品点
数に限られる。また、これらの部品にあっては摺動、摺
接関係を有する部材は全くない。このため、医療用容器
1は組立が簡単であり、他の薬剤容器4の接続に際して
も簡単にできる。また、連結筒部材11の連結口13に
通気性の保護シート16を設けることにより、本体2の
薬液3と共に除菌フィルタ15を蒸気滅菌することがで
き、また保存時まで清潔に維持させることができる。そ
して、隔離シール部12の形成により、除菌フィルタ1
5はその使用時まで薬液に浸ることがない。このため、
保存時に劣化を起こすおそれもない。また、医療用容器
1の使用にあっては、保護シート15を連結口13から
剥がし、薬剤容器4の口部4Aを連結口13に挿入し、
薬剤容器4を連結筒部材11と接続する。次に、容器本
体2を手などで圧迫して隔離シール部12を剥離させ、
連結筒部材11内に薬液3を流し込み、その薬液3で薬
剤容器4内の薬剤を溶解させる。溶解して再び薬液3を
戻した後、排出口部材9に点滴用の連通針を差し込んで
点滴を開始する。従って、混注、点滴操作も極めて簡単
にできる。上記第一実施例では、連結口13に保護シー
ト15を貼着したが、図2に示す如く、薬剤容器4を無
菌室等で予め連結口13に取り付けれ、フルキット医療
用容器として提供しても良い。上記第一実施例では、容
器本体2にインフレーションフィルムを用いたが、ブロ
ー成形物を容器本体に用いても良い。また上記実施例で
は医療用容器1を輸液用のバックとしたが、透析液用の
バック、臓器保存用のバック等に用いても良い。尚、上
記実施例の連結部をガスバリアー性の包装体で包装して
も良い。The medical container 1 constructed as described above comprises a resin container main body 2, a connecting cylinder member 11, an elastic ring, and a sterilizing filter, and is limited to a very small number of parts. In addition, there is no sliding or sliding member in these parts. Therefore, the medical container 1 is easy to assemble, and can be easily connected to another medicine container 4. Further, by providing the gas-permeable protective sheet 16 at the connection port 13 of the connection cylinder member 11, the sterilization filter 15 can be steam-sterilized together with the chemical solution 3 of the main body 2, and can be kept clean until storage. it can. Then, the sterilization filter 1 is formed by forming the isolation seal portion 12.
5 does not soak in chemicals until its use. For this reason,
There is no risk of deterioration during storage. When using the medical container 1, the protective sheet 15 is peeled off from the connection port 13, and the mouth 4A of the medicine container 4 is inserted into the connection port 13,
The medicine container 4 is connected to the connecting cylinder member 11. Next, the container body 2 is pressed by hand or the like to peel off the isolation seal portion 12,
The drug solution 3 is poured into the connecting cylinder member 11, and the drug in the drug container 4 is dissolved by the drug solution 3. After dissolving and returning the chemical solution 3 again, a drip communication needle is inserted into the outlet member 9 to start drip infusion. Therefore, co-infusion and infusion operations can be extremely easily performed. In the first embodiment, the protective sheet 15 is attached to the connection port 13, but as shown in FIG. 2, the medicine container 4 is attached to the connection port 13 in a sterile room or the like in advance and provided as a full kit medical container. Is also good. In the first embodiment, the blown film is used for the container body 2, but a blow molded product may be used for the container body. In the above embodiment, the medical container 1 is used as a bag for infusion. However, the medical container 1 may be used as a bag for dialysate, a bag for storing organs, and the like. In addition, you may package the connection part of the said Example with the packaging body of a gas barrier.
【0019】[0019]
【発明の効果】以上説明したように本発明に係る医療用
容器においては、薬液が収容された樹脂製の本体であっ
て、上記薬液に混注される薬剤を収容した薬剤容器を連
結するための連結部を有する本体からなり、上記本体に
隔離シール部を形成し、該隔離シール部で上記薬液の収
容部と上記連結部とを隔離し、上記隔離シール部を剥離
可能なシール部とすると共に、上記連結部の連結口に弾
性リング材及び除菌フィルタを設け、上記連結口と薬剤
容器の口部とは弾性リング材及び除菌フィルタを介して
液密に連結しうるので、連結部の取付が簡単で、連結部
の無菌維持及び安全性が高く、更には使用の際の混注、
混合操作が容易にできる。As described above, the medical container according to the present invention is a resin main body containing a drug solution, and is used for connecting a drug container containing a drug mixed with the drug solution. A main body having a connecting portion, a separating seal portion is formed on the main body, the separating seal portion separates the storage portion for the chemical solution from the connecting portion, and the separating seal portion is a peelable seal portion. An elastic ring material and a sterilization filter are provided at the connection port of the connection section, and the connection port and the mouth of the medicine container can be liquid-tightly connected via the elastic ring material and the sterilization filter. Easy installation, high aseptic maintenance and safety of connecting part, and co-injection when using,
Mixing operation can be easily performed.
【図1】図1は本発明に係る医療用容器の第一実施例の
正面図である。FIG. 1 is a front view of a first embodiment of a medical container according to the present invention.
【図2】図2は第一実施例の医療用容器に薬剤容器を取
り付けた正面図である。FIG. 2 is a front view in which a medicine container is attached to the medical container of the first embodiment.
【図3】図3は第一実施例の医療用容器に用いられる除
菌フィルタの平面図である。FIG. 3 is a plan view of a sterilization filter used in the medical container of the first embodiment.
1 医療用容器 2 樹脂製の容器本体 3 薬液 4 薬剤容器 5 薬剤 11 連結筒部材 12 隔離シール部 14 弾性リング材 15 除菌フィルタ DESCRIPTION OF SYMBOLS 1 Medical container 2 Resin container main body 3 Chemical solution 4 Drug container 5 Drug 11 Connecting cylinder member 12 Isolation seal part 14 Elastic ring material 15 Disinfection filter
Claims (3)
上記薬液に混注される薬剤を収容した薬剤容器を連結す
るための連結部を有する本体からなる医療用容器におい
て、 上記本体に隔離シール部を形成し、該隔離シール部で上
記薬液の収容部と上記連結部とを隔離し、上記隔離シー
ル部を剥離可能なシール部とすると共に、上記連結部の
連結口に弾性リング材及び除菌フィルタを設け、上記連
結口と薬剤容器の口部とは弾性リング材及び除菌フィル
タを介して液密に連結しうることを特徴とする医療用容
器。1. A resin body containing a chemical solution,
In a medical container comprising a main body having a connecting portion for connecting a medicine container containing a medicine mixed with the medicinal solution, an isolating seal portion is formed in the main body, and the medicinal solution housing portion is formed by the isolating seal portion. The connecting portion is separated from the sealing portion, and the separating seal portion is formed as a peelable seal portion.An elastic ring material and a sterilization filter are provided at a connecting port of the connecting portion. A medical container capable of being connected in a liquid-tight manner via an elastic ring material and a sterilization filter.
し、上記保護シール材は通気性シートからなり、上記連
結部内を上記容器本体内と共に蒸気滅菌処理しているこ
とを特徴とする請求項1記載の医療用容器。2. The method according to claim 1, wherein a protective sealing material is hermetically adhered to the connecting port, the protective sealing material is made of a breathable sheet, and the inside of the connecting portion is steam sterilized together with the inside of the container body. The medical container according to claim 1.
けられ、上記薬剤容器内は上記本体内と通じていること
を特徴とする請求項1記載の医療用容器。3. The medical container according to claim 1, wherein the other medicine container is already provided at the connection port, and the inside of the medicine container communicates with the inside of the main body.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9157568A JPH10328269A (en) | 1997-05-30 | 1997-05-30 | Medical container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9157568A JPH10328269A (en) | 1997-05-30 | 1997-05-30 | Medical container |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10328269A true JPH10328269A (en) | 1998-12-15 |
Family
ID=15652540
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9157568A Pending JPH10328269A (en) | 1997-05-30 | 1997-05-30 | Medical container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH10328269A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072175A1 (en) * | 2001-03-05 | 2002-09-19 | Nipro Corporation | Chemical liquid injection port, and chemical liquid container having the same |
US7322969B2 (en) | 2001-09-14 | 2008-01-29 | Nipro Corporation | Liquid-medicine injection port device, and liquid-medicine container provided with the same |
WO2016045599A1 (en) * | 2014-09-25 | 2016-03-31 | 胡绍勤 | Precise filtering transfusion container |
-
1997
- 1997-05-30 JP JP9157568A patent/JPH10328269A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002072175A1 (en) * | 2001-03-05 | 2002-09-19 | Nipro Corporation | Chemical liquid injection port, and chemical liquid container having the same |
KR100816974B1 (en) * | 2001-03-05 | 2008-03-26 | 니프로 가부시키가이샤 | Chemical liquid injection port and chemical liquid container having the same |
JP2009178584A (en) * | 2001-03-05 | 2009-08-13 | Nipro Corp | Chemical liquid injection port, and chemical liquid container having the same |
US7322969B2 (en) | 2001-09-14 | 2008-01-29 | Nipro Corporation | Liquid-medicine injection port device, and liquid-medicine container provided with the same |
WO2016045599A1 (en) * | 2014-09-25 | 2016-03-31 | 胡绍勤 | Precise filtering transfusion container |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2828505B2 (en) | Flexible container and method of forming the same | |
JP2002224195A (en) | Transfusion container | |
US6308847B1 (en) | Medical containers | |
EP0904234B1 (en) | Improved medical containers | |
JP4697398B2 (en) | Preparation kit for injection and syringe containing medicine | |
JP5512586B2 (en) | Medical multi-chamber container | |
JPH10328269A (en) | Medical container | |
JP2000107257A (en) | Transfusion bag | |
JP4335334B2 (en) | Drug infusion container | |
JPH09173416A (en) | Manufacture of medical container | |
JPH0919480A (en) | Medical vessel | |
JPH10314273A (en) | Medical vessel | |
JP3834158B2 (en) | Multi-chamber container | |
JPH0975425A (en) | Medical vessel | |
JPH1128243A (en) | Medical container | |
JPH10218252A (en) | Container for storing multi-constituent | |
JPH09108302A (en) | Medical container and its manufacture | |
JPH11379A (en) | Medical container | |
JP2000107256A (en) | Drug mixed infusion bag | |
JPH10165479A (en) | Medical container | |
JPH09276370A (en) | Medical vessel and manufacturing method thereof | |
JPH10216200A (en) | Preparation of container for medical treatment | |
JPH10328270A (en) | Freeze drying container and manufacture of medical container using it | |
JPH1085305A (en) | Medical container | |
JP4118305B2 (en) | Multi-chamber container |